Tesamorelin from bench to bedside FDA approval
Shownotes
This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.
Topics include:
- Tesamorelin peptide mechanism of action
- Preclinical and animal studies
- Phase II and Phase III clinical trial data
- FDA approval and HIV-associated lipodystrophy
- Growth hormone, IGF-1, and metabolic effects
- Safety, limitations, and ongoing research